| GLP-1 Analogues Market: $47.4B to $471.1B Growth Forecast (2024-2032) |
| https://finance.yahoo.com/news/glp-1-analogues-market-47-123000064.html |
| Novo Nordisk A/S, based in Denmark, is a leading player in the GLP-1 Analogue market, significantly contributing with its robust product portfolio, strong brand recognition, and extensive global distribution channels. |
| read more |
|
|
| Navigating the Cider Boom: Market Set to Grow from USD 15.4 Billion to USD 23.77 Billion by 2030 |
|
| The size of the global smart dust market was estimated at USD 159.37 million in 2023, and over the course of the forecast period, the market is projected to grow at a CAGR of 14% to reach USD 398.79 million by 2030.Cider Market OverviewMaximize Marke |
| read more |
|
|
| Fresh Vegetables Market Size Expected to Reach USD 825.06 Billion by 2030 |
|
| Fresh Vegetables Market Report Scope and Research MethodologyThe goal of the Fresh Vegetables Market study is to provide a complete assessment of the market, including thoughtful insights, facts, historical data, industry-validated market s |
| read more |
|
|
| Label-Free Detection Market worth $747 million by 2029 |
| https://www.prnewswire.com/news-releases/label-free-detection-market-worth-747-million-by-2029-driven-by-technological-advancements--marketsandmarkets-3022 |
| Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the market |
| read more |
|
|
| Intracardiac Echocardiography (ICE) Market worth $545 million by 2029 |
| https://www.prnewswire.com/news-releases/intracardiac-echocardiography-ice-market-worth-545-million-by-2029-driven-by-technological-advancements--marketsan |
| North America emerged as the dominant region, holding the largest market share |
| read more |
|
|
| Genotyping Assay Market Size, Share & Growth Trends |
| https://www.globenewswire.com/en/news-release/2024/07/08/2909623/0/en/Genotyping-Assay-Market-19-4B-to-37-1B-Growth-Forecast-2024-2029-MarketsandMarkets.ht |
| This growth is driven by advancements in technology, reduced DNA sequencing costs, and the rising prevalence of genetic disorders. |
| read more |
|
|
